Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Patent Profile: Chemokine Therapeutics Announces Issuance of Two Patents for Chemokine-Based Therapies

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Kwame Mensah -- Last month, Chemokine Therapeutics Corp. announced that it has been granted U.S. Patent Nos. 7,354,899, entitled "Methods of treating Autoimmune Diseases Comprising Administering CXCR4 Antagonists" and 7,368,425, entitled "Cyclic Peptides for Modulating Growth of Neo-Vessels and Their Use in Therapeutic Angiogenesis." With the issuance of the '899 and '425 patents, Chemokine's portfolio now includes at least seven U.S. patents and five U.S. patent publications. Chemokine stated that the filing of the '899 patent, which is related to the treatment of a wide range of autoimmune and inflammatory diseases such as multiple sclerosis, arthritis, and psoriasis, was...

Full post as published by Patent Docs on June 25, 2008 (boomark / email).